News

The Manila Times1d
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...
The Manila Times2d
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...